-
Loading metrics
Plasma cell-free DNA measured prior to renal replacement therapy initiation is not associated with incident adverse outcomes, hospitalizations or malignancies in chronic kidney disease stage 4–5 patients
- Niilo Liuhto,
- Jenni Tuominen,
- Noora Manni,
- Markus Hakamäki,
- Roosa Lankinen,
- Tomi Toukola,
- Jonna Virtanen,
- Kaj Metsärinne,
- Mikko J. Järvisalo,
- Tapio Hellman
x
- Published: July 7, 2026
- https://doi.org/10.1371/journal.pone.0353258